web analytics

Binit

Binit Kumar is an engineer, investor, and author of two finance books with 16+ years of experience investing in mutual funds and stocks. He specializes in IPOs, mutual funds, investing, and long-term wealth creation. Investing Book: 60 Minutes Guide to Building Wealth – https://www.amazon.com/60-Minutes-Guide-Building-Wealth-ebook/dp/B0C6GYDC53/ Amazon Author Page: https://www.amazon.com/stores/Binit-Kumar/author/B0FV11D7S3

Lumino Industries IPO Review: PAT Jumped 85%, P/E at 12.48 & Full Analysis

Lumino Industries Limited operates as a major Indian manufacturer of advanced electrical cables, conductors, and power transmission equipment.The Kolkata-headquartered company functions through two distinct operational segments, focusing heavily on in-house manufacturing while selectively executing specialised Engineering, Procurement, and Construction (EPC) contracts for high-voltage substations.For its public market debut, the Lumino Industries IPO will accept subscriptions […]

Lumino Industries IPO Review: PAT Jumped 85%, P/E at 12.48 & Full Analysis Read More »

Annu Projects IPO Review: PAT Jumped 90%, P/E at 14.33 & Full Analysis

Annu Projects Limited operates as a multidisciplinary engineering, procurement, and construction (EPC) company based in New Delhi, specialising primarily in sewerage infrastructure, telecom networks, and civil construction projects.As Annu Projects transitions to the public markets, its IPO will remain open for subscription from August 25 to August 28, 2026, with the price band fixed at

Annu Projects IPO Review: PAT Jumped 90%, P/E at 14.33 & Full Analysis Read More »

Hy-Tech Engineers IPO Review: PAT Jumped 95%, P/E at 19.63 & Full Analysis

Hy-Tech Engineers Limited operates as an established precision engineering company, specialising in the manufacturing of hydraulic valves, fittings, and associated fluid connector components for diverse sectors including automotive, construction, and agriculture. Investors can bid on the Hy-Tech Engineers mainboard IPO between August 24 and August 27, 2026. To raise up to ₹136.00 crore, the company is

Hy-Tech Engineers IPO Review: PAT Jumped 95%, P/E at 19.63 & Full Analysis Read More »

Symbiotec Pharmalab IPO Review: Revenue Up 21%, P/E at 51.72 & Full Analysis

Symbiotec Pharmalab Limited is an established, vertically integrated Indian pharmaceutical company specializing in the research, development, and manufacturing of high-barrier active pharmaceutical ingredients (APIs), specifically corticosteroids and steroidal hormones.The company is transitioning to the public markets to deleverage its balance sheet and provide a partial exit to existing investors. The public subscription window for the

Symbiotec Pharmalab IPO Review: Revenue Up 21%, P/E at 51.72 & Full Analysis Read More »

Madhur Knit Crafts IPO Review: PAT Jumped 549%, P/E at 11.75 & Full Analysis

Madhur Knit Crafts Limited operates as an established textile manufacturer in Ludhiana, Punjab, featuring a fully vertically integrated “yarn-to-cloth” business model.The company produces various knitted fabrics, garments, and blankets for apparel and industrial uses.Transitioning to the public markets, the Madhur Knit Crafts IPO opens for public subscription on August 24, 2026, and closes on August

Madhur Knit Crafts IPO Review: PAT Jumped 549%, P/E at 11.75 & Full Analysis Read More »

Sumax Engineering IPO Review: PAT Jumped 72%, P/E at 11.66 & Full Analysis

Sumax Engineering Limited operates as a specialised manufacturer and supplier of customized adhesive tapes, abrasives, and die-cut products primarily serving Tier-1 automotive OEMs and the auto refinish segment.The Sumax Engineering IPO, marking the enterprise’s transition to the public markets, opens on August 25, 2026, and closes on August 28, 2026, with the company aiming to

Sumax Engineering IPO Review: PAT Jumped 72%, P/E at 11.66 & Full Analysis Read More »

Augmont Enterprises IPO Review: Revenue Jumped 170%, P/E at 19.48 & Full Analysis

Augmont Enterprises Limited operates as a highly integrated precious metals enterprise in India, commanding a dominant presence across the bullion value chain through its B2B trading platform “Augmont SPOT” and retail digital gold portal “Augmont Gold For All”.The firm operates two advanced refineries and offers comprehensive solutions, including gold SIPs, scrap recycling, and jewellery exports.Scheduled

Augmont Enterprises IPO Review: Revenue Jumped 170%, P/E at 19.48 & Full Analysis Read More »

LEAP India IPO Listing Analysis: 104.61x P/E, 6.71x Subscription & ₹13 GMP — Why Did It List at Just 4.34%?

LEAP India Limited made a positive debut on the NSE, listing at ₹165.90 against its issue price of ₹159, delivering a 4.34% listing gain.What makes the listing interesting is that the final grey-market premium had indicated a considerably higher price. LEAP India’s final ₹13 GMP implied a listing price of ₹172, or a potential premium

LEAP India IPO Listing Analysis: 104.61x P/E, 6.71x Subscription & ₹13 GMP — Why Did It List at Just 4.34%? Read More »

ABH Healthcare IPO Review: PAT Jumped 240%, P/E at 14.47 & Full Analysis

ABH Healthcare Limited, established in 1985 as Anil Baghi Hospital, operates as a prominent multi-specialty medical services provider based in Ferozepur, Punjab.The hospital offers a comprehensive range of high-end clinical specialties, including cardiology, orthopaedics, and internal medicine.The ABH Healthcare IPO, marking the enterprise’s transition to the public markets, opens on August 24, 2026, and closes

ABH Healthcare IPO Review: PAT Jumped 240%, P/E at 14.47 & Full Analysis Read More »

Tempsens Instruments IPO Review: Revenue Jumped 64%, EBITDA Margin at 24.83% & Full Analysis

Tempsens Instruments (India) Limited operates as a leading manufacturer of temperature sensors, electrical heating solutions, and specialised cables, catering to critical industries such as metals, petrochemicals, aerospace, and defence.Holding a dominant domestic market share in contact and non-contact sensors, the company is transitioning to the public markets to scale up its global and domestic footprint. The

Tempsens Instruments IPO Review: Revenue Jumped 64%, EBITDA Margin at 24.83% & Full Analysis Read More »

Scroll to Top